Experienced in Increased Intracranial Pressure

Mervi H. Taskinen

Haartmaninkatu 4, PL 372, 
Helsinki, FI 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Increased Intracranial Pressure
Haartmaninkatu 4, PL 372, 
Helsinki, FI 
OverviewLocationsClinical Research

Overview

Mervi Taskinen practices in Helsinki, Finland. Taskinen is rated as an Experienced expert by MediFind in the treatment of Increased Intracranial Pressure. Their top areas of expertise are Cartilage-Hair Hypoplasia, Chondrodystrophy, X-Linked Spondyloepiphyseal Dysplasia Tarda, Bone Marrow Transplant, and Oophorectomy.

Their clinical research consists of co-authoring 89 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Increased Intracranial Pressure.

Locations

Haartmaninkatu 4, PL 372, Helsinki, 00029, Finland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
Enrollment Status: Recruiting
Publish Date: August 28, 2025
Intervention Type: Drug
Study Drugs: Doxorubicin, Vincristine, Dexamethasone, Inotuzumab, Imatinib, 6-Tioguanine, Blinatumomab
Study Phase: Phase 3

89 Total Publications

Graft-Versus-Host Disease Sustains Coagulation Activity for two Years After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
Graft-Versus-Host Disease Sustains Coagulation Activity for two Years After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: February 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Taskinen's expertise for a condition
ConditionClose
View All 35 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile